G1GLP1 Note Applies to All countries

HomeGenericsSemaglutide

GenericAll countries · Checked

Generic Semaglutide: Where It Is Approved and What It Costs

As of November 20, 2026, generic semaglutide injections are approved in Canada and sold in India, and two Canadian generics of Ozempic are listed by BC PharmaCare, for both type 2 diabetes and weight management. Brazil has registered its own synthetic semaglutide pens, India prices run INR 1,800 to INR 4,200 a month, and the US ingredient patent runs to 2032.

Is there a generic semaglutide?

In some countries, yes. Generics exist in Canada and India, Brazil has registered synthetic semaglutide pens, and there is none in the US yet.

CanadaApproved April 28 and June 29, 2026

IndiaLaunched March 21, 2026

BrazilSynthetic pen registered May 26, 2026

United StatesPatent to 2032

Based on Health Canada, Anvisa (which does not call the Brazilian pens generics) and Indian company announcements and Novo Nordisk's patent table.

What you pay depends a lot on where you live.

See what semaglutide costs in each country

Looking at India? See semaglutide injection price in India.

What it isSemaglutide generic nameUSCanadaIndiaBrazilPricePatentSame drug?Generics of other weight loss drugsFAQ

Generic semaglutide

Semaglutide is the ingredient. Wegovy, Ozempic and Rybelsus are the brand names that carry it.

A generic semaglutide is the same ingredient made by another company and approved by a regulator. The maker and the product name change.

An expired patent does not put a generic on the shelf by itself. A regulator has to approve each product in each country.

What the drug does is covered in semaglutide for weight loss.

Semaglutide generic name

Semaglutide is already the generic name. It is the ingredient name, with no brand attached.

Generic products still get a name from the company, such as Obeda and Noveltreat in India and Sevmia in Canada. Brazil's Ozivy is a synthetic semaglutide pen, which Anvisa does not call a generic.

On the box, the product name is followed by the ingredient, semaglutide.

Generic semaglutide in the US

No generic semaglutide is confirmed in the US. Novo Nordisk lists the ingredient patent as running to 2032 for Wegovy, Ozempic and Rybelsus.

So you use the brand today. Prices are in semaglutide cost in the US, and the maker's offer is in Wegovy coupon and savings card.

Generic semaglutide in Canada

Health Canada approved Dr. Reddy's generic semaglutide injection on April 28, 2026, the first in the G7. It is a generic of Ozempic, for adults with type 2 diabetes.

On June 29, 2026, it approved Apotex's Sevmia, a generic of Wegovy for chronic weight management in people 12 and older.

Health Canada said six more submissions were under review after the Sevmia decision (eight when it approved Dr. Reddy's in April). It gave no launch date or price for Sevmia, and no launch of Sevmia is confirmed here.

The two Ozempic generics are on the market. Apotex announced the launch of its Apo-Semaglutide injection on May 14, 2026, and on June 15, 2026 BC PharmaCare listed the Apotex and Dr. Reddy's generics at a 65% discount to Ozempic.

Canadian prices are in Wegovy cost Canada and Ozempic price Canada.

Generic semaglutide in India

In India, several companies launched generic semaglutide on March 21, 2026, right after the patent expired.

Generic semaglutide products in India

Dr. Reddy's ObedaType 2 diabetes, 2 mg and 4 mg pens

Sun Pharma NoveltreatWeight management, five strengths from 0.25 mg to 2.4 mg

Sun Pharma SematrinityType 2 diabetes, 2 mg and 4 mg

Alkem Semasize, Obesema, HepaglideType 2 diabetes and weight management

The list covers products confirmed in company releases, and there may be more.

Each product has its own approved use, so check which one your prescriber means before you compare prices.

Brand prices are in Wegovy price in India and Ozempic price in India.

Generic semaglutide in Brazil

Brazil's regulator Anvisa registered EMS's Ozivy on May 26, 2026, the first synthetic semaglutide pen made as an analog of Ozempic. Anvisa says the Ozempic patent there expired on March 20.

Ozivy is for adults with uncontrolled type 2 diabetes. Its storage differs from Ozempic, so read the leaflet that comes with your pen.

On October 29, 2026, Anvisa also registered two diabetes semaglutide pens, Embeltah (Dr. Reddy's) and Sevema (Aché). Anvisa does not label any of these brands generic.

Generic semaglutide injection price

Published prices are confirmed only in India. Dr. Reddy's Obeda costs INR 4,200 a month, and Alkem's monthly pen starts at INR 1,800.

Alkem puts that at INR 450 a week and also sells a reusable pen for higher maintenance doses.

In Canada, BC PharmaCare says the Ozempic generics are priced at a 65% discount to Ozempic, but no Sevmia price is announced. In Brazil, no generic price has been announced yet.

To see what a month of treatment costs for you, use the GLP-1 cost calculator.

When does the semaglutide patent end?

Semaglutide ingredient patent expiry, as listed by Novo Nordisk

United States2032

Europe2031

Japan2031

China2026

The table is the same for Wegovy, Ozempic and Rybelsus. Other patents on manufacturing or use can run longer.

Is generic semaglutide the same as Wegovy and Ozempic?

The ingredient is the same. The pen, the strengths and the storage rules can differ by product.

Dr. Reddy's reports that Obeda showed non-inferior efficacy and similar safety to the innovator drug in its trial in India.

Switching to a generic, or changing your dose, is a decision for your prescriber. Brand dose steps are in semaglutide dosing chart.

Each brand has its own page: Wegovy generic name, generic Ozempic and generic Rybelsus.

Generics of other weight loss drugs

Tirzepatide is a different drug. See Mounjaro generic name.

Liraglutide is an older drug and already has generics in several countries. See generic liraglutide.

The whole class is in generic GLP-1 drugs.

Generic semaglutide FAQ

Is there a generic semaglutide?

Yes, in some countries. Generics exist in Canada and India, Brazil has registered synthetic semaglutide pens, and none is in the US.

What is the generic name for semaglutide?

Semaglutide itself. Each generic product also has a company name, such as Obeda or Sevmia.

Is generic semaglutide approved for weight loss?

Some are. Sevmia in Canada and Noveltreat in India are announced for weight management, while Obeda is for diabetes. Brazil's Ozivy, Embeltah and Sevema are diabetes pens that Anvisa does not call generics.

How much is generic semaglutide?

In India, INR 1,800 a month and up from Alkem, and INR 4,200 from Dr. Reddy's. Other countries have no announced price yet.

When will generic semaglutide come to the US?

Novo Nordisk lists the ingredient patent to 2032, and no earlier US generic is confirmed.

Keep reading

Wegovy generic name

Generic Ozempic

Semaglutide injection price in India

Semaglutide dosing chart

Mounjaro generic name

This page follows regulator and company announcements and is updated when the status changes. See how we check our pages.

Update log

: First published.

Sources

Canada becomes the first G7 country to approve a generic version of semaglutide (Health Canada, April 28, 2026).

Canada approves first generic semaglutide for weight loss (Health Canada, June 29, 2026).

Dr. Reddy's launch of Obeda in India (press release, March 21, 2026).

Alkem launches semaglutide injection in India (press release, March 21, 2026).

Anvisa approves the first synthetic semaglutide pen for diabetes (Anvisa, Brazil, May 27, 2026).

Patent status for products with marketing authorisation (Novo Nordisk Annual Report 2025).

Anvisa aprova cinco novas canetas de GLP-1 (Anvisa, Brazil, October 29, 2026).

GLP1 Note is an independent information site. Your own treatment is decided by your prescriber.